Oxygenta Pharmaceutical Ltd. - Research Center
524636 OXYGENTAPH Group (XT) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
10.55 |
9.15 |
13.08 |
6.86 |
8.19 |
Operating profit |
-1.61 |
-2.47 |
-1.98 |
-3.64 |
-2.25 |
Interest |
0.59 |
0.36 |
0.34 |
0.29 |
0.94 |
Gross profit |
-2.20 |
-2.81 |
-2.32 |
-3.93 |
-3.19 |
EPS (Rs) |
2.39 |
-1.13 |
-0.94 |
-1.36 |
-3.02 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
0.01 |
0.03 |
- |
- |
- |
Stock adjustment |
-2.12 |
1.80 |
-0.14 |
-1.07 |
-0.78 |
Raw material |
9.04 |
6.25 |
11.68 |
8.09 |
7.35 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
5.25 |
0.24 |
0.33 |
0.18 |
0.42 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
- |
3.33 |
3.19 |
3.30 |
3.44 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
0.64 |
0.69 |
0.83 |
0.50 |
0.85 |
Taxation |
-10.60 |
0.23 |
-0.02 |
- |
0.20 |
Net profit / loss |
8.02 |
-3.78 |
-3.16 |
-4.56 |
-4.29 |
Extra ordinary item |
0.25 |
-0.05 |
-0.03 |
-0.13 |
-0.05 |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
33.48 |
33.48 |
33.48 |
33.48 |
14.20 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-15.30 |
-27.00 |
-15.11 |
-52.97 |
-27.45 |
GPM (%) |
-20.79 |
-30.57 |
-17.71 |
- |
-38.92 |
NPM (%) |
75.87 |
-41.15 |
-24.17 |
- |
-52.41 |